Klotho Neurosciences Inc (KLTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 845 | 8 | 3 | 146 | 124 |
| TOTAL | $1,000 | $8 | $7 | $204 | $259 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 19,578 | 0 | 57,812 | 56,950 |
| Intangibles | 2,310 | 0 | 2,186 | 0 | 0 |
| TOTAL | $2,310 | $19,578 | $2,186 | $57,812 | $56,950 |
| Total Assets | $3,309 | $19,586 | $2,193 | $58,016 | $57,209 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 65 | 815 | 151 | 0 | 0 |
| Accrued Expenses | 250 | N/A | 3 | 328 | 274 |
| Other current liabilities | 15 | N/A | N/A | N/A | N/A |
| TOTAL | $899 | $2,583 | $1,621 | $1,664 | $1,352 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,962 | 24,713 | 0 | 62,736 | 61,775 |
| TOTAL | $3,962 | $24,731 | $N/A | $62,787 | $61,903 |
| Total Liabilities | $4,861 | $27,315 | $1,621 | $64,451 | $63,255 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,230 | 5,165 | 1,760 | 8,802 | 8,802 |
| Common Shares | 2 | 0 | 2 | 0 | 0 |
| Retained earnings | -5,536 | -7,729 | -3,924 | -6,436 | -6,046 |
| Other shareholders' equity | 304 | 0 | 0 | 0 | 0 |
| TOTAL | $-1,551 | $-7,728 | $572 | $-6,436 | $-6,046 |
| Total Liabilities And Equity | $3,309 | $19,586 | $2,193 | $58,016 | $57,209 |